Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2 studies found for:    17318210 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Tetracycline as a Prophylaxis for Rash in Patients With NSCLC Receiving Treatment With BIBW2992 (Afatinib)
Conditions: Skin Rash;   Lung Cancer
Intervention: Drug: Tetracycline
2 Active, not recruiting Treatment With BIBW 2992, Irreversible Inhibitor of EGFR and HER-2 in Non Small Cell Lung Cancer
Conditions: Non-Small Cell Lung Cancer;   EGFR;   HER-2
Intervention: Drug: BIBW 2992

Study has passed its completion date and status has not been verified in more than two years.